Maravai Lifesciences Holdings (MRVI) Return on Capital Employed (2021 - 2026)

Maravai Lifesciences Holdings' Return on Capital Employed history runs 6 years deep, the most recent figure standing at 24.06% for Q1 2026.

• In Q1 2026, Return on Capital Employed rose 482.0% year-over-year to 24.06%; the TTM figure through Mar 2026 stood at 24.06% (up 482.0% YoY), while the FY2025 annual figure was 25.49%, down 571.0% from the prior year.
• Return on Capital Employed was 24.06% for Q1 2026 at Maravai Lifesciences Holdings, up from 28.14% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 33.3% in Q1 2022 to a low of 37.12% in Q2 2025.
• Historically, Return on Capital Employed has averaged 2.01% across 5 years, with a median of 3.77% in 2024.
• The sharpest annual moves came in 2022 and 2025: Return on Capital Employed surged 1792 bps in 2022, then sank 3313 bps in 2025.
• A 5-year view of Return on Capital Employed shows it stood at 26.64% in 2022, then plunged by 107 bps to 1.77% in 2023, then plunged by 1127 bps to 21.69% in 2024, then slipped by 30 bps to 28.14% in 2025, then climbed by 14 bps to 24.06% in 2026.
• The last three Return on Capital Employed figures came in at 24.06% (Q1 2026), 28.14% (Q4 2025), and 23.93% (Q3 2025), per Business Quant data.